載入...
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
Bronchodilators, including long-acting β(2)-agonists and long-acting muscarinic antagonists, are the mainstay for treatment of patients with chronic obstructive pulmonary disease (COPD) to prevent exacerbations or reduce symptoms. Formoterol is a highly selective and potent β(2)-agonist that relaxes...
Na minha lista:
| 發表在: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708267/ https://ncbi.nlm.nih.gov/pubmed/33273813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S273497 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|